02211.HK
Universal Health International Group Holding Limited
HKSE · Healthcare · Medical - Pharmaceuticals · CN
HKD 0.45
+2.27%Year over year
Reported trailing growth
- Revenue
- -27.0%
- EBITDA
- +222.8%
- EBIT
- +71.5%
- EPS
- +25.2%
- Free cash flow
- +132.2%
- Operating cash flow
- +132.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -26.2%
- EBITDA
- -30.0%
- EBIT
- +71.4%
- Net income
- +21.2%
- EPS
- +53.1%
- Free cash flow
- +100.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026